Tensegrity Pharma, Inc.
PrivateLast Round
Seed
Nov 13, 2024
Total Funding Raised
$4.15M
Momentum
Top 10%
of companies Caplight tracks
Company Overview
Tensegrity Pharma, Inc. operates in Healthcare & Life Sciences and is based in Tokyo. Its latest recorded funding round was a Seed round in November 2024.
Tensegrity Pharma, Inc. is a biotechnology company that develops therapeutic candidates by reclaiming and advancing strategically discontinued drug projects for clinical validation.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Clinical Trials, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Tensegrity Pharma, Inc. Comparables
Compare Tensegrity Pharma, Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Actimed Therapeutics | 82% | |
| Artelo Biosciences, Inc. | 71% | |
| Pfizer | 66% |
For institutional investors. Book with your work email.
Tensegrity Pharma, Inc. Funding Rounds
Historical fundraising activity
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Tensegrity Pharma, Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Newton Biocapital | Seed |
| Mitsubishi UFJ Capital | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Sep 16, 2026
Grew 43% QoQ from 7 to 10 employees.
- Dec 24, 2025
Grew 100% QoQ, from 4 to 8 employees.
For institutional investors. Book with your work email.
Tensegrity Pharma, Inc. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Tensegrity Pharma, Inc.'s valuation, stock price, and market status.
Is Tensegrity Pharma, Inc. a public or private company?
Tensegrity Pharma, Inc. is a private company.
What is the current stock price of Tensegrity Pharma, Inc.?
Tensegrity Pharma, Inc. is a private company, so its shares have no public market price. Caplight tracks Tensegrity Pharma, Inc.'s secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Tensegrity Pharma, Inc. worth (valuation)?
Valuation information for Tensegrity Pharma, Inc. is not publicly available.
Can I buy Tensegrity Pharma, Inc. stock?
Tensegrity Pharma, Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Tensegrity Pharma, Inc.'s last funding round?
Tensegrity Pharma, Inc.'s most recent funding round was Seed on November 13, 2024.
Who are the main investors in Tensegrity Pharma, Inc.?
Key investors in Tensegrity Pharma, Inc. include Newton Biocapital.
Will Tensegrity Pharma, Inc. IPO soon?
No public IPO plans have been announced for Tensegrity Pharma, Inc..
How can I track Tensegrity Pharma, Inc. secondary market activity?
Caplight tracks bids, offers, and trades in Tensegrity Pharma, Inc.'s shares on secondary markets.